Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126928391 | 12692839 | 1 | I | 201604 | 20160818 | 20160829 | 20160829 | EXP | DE-BFARM-16279141 | DE-ALVOGEN-2016-ALVOGEN-028043 | ALVOGEN | 51.00 | YR | F | Y | 0.00000 | 20160829 | MD | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126928391 | 12692839 | 1 | PS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | Oral | N | 62800 | 600 | MG | CAPSULE, HARD | TID | ||||||
126928391 | 12692839 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | N | 0 | 500 | MG | BID | |||||||
126928391 | 12692839 | 3 | SS | PIPERACILLIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | N | 0 | 4.5 | G | TID | |||||||
126928391 | 12692839 | 4 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | 0 | ||||||||||||
126928391 | 12692839 | 5 | C | TRAMAL LONG | TRAMADOL | 1 | 0 | ||||||||||||
126928391 | 12692839 | 6 | C | NOVALGIN | METAMIZOLE SODIUM | 1 | 0 | ||||||||||||
126928391 | 12692839 | 7 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
126928391 | 12692839 | 8 | C | MONO-EMBOLEX | CERTOPARIN SODIUM | 1 | 0 | ||||||||||||
126928391 | 12692839 | 9 | SS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | N | 62800 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126928391 | 12692839 | 1 | Osteitis |
126928391 | 12692839 | 2 | Osteitis |
126928391 | 12692839 | 3 | Osteitis |
126928391 | 12692839 | 4 | Product used for unknown indication |
126928391 | 12692839 | 5 | Product used for unknown indication |
126928391 | 12692839 | 6 | Product used for unknown indication |
126928391 | 12692839 | 7 | Product used for unknown indication |
126928391 | 12692839 | 8 | Product used for unknown indication |
126928391 | 12692839 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126928391 | 12692839 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126928391 | 12692839 | Epicondylitis | |
126928391 | 12692839 | Sensory loss | |
126928391 | 12692839 | Tendon pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126928391 | 12692839 | 1 | 20160325 | 20160402 | 0 | |
126928391 | 12692839 | 2 | 20160402 | 20160419 | 0 | |
126928391 | 12692839 | 3 | 20160402 | 20160407 | 0 | |
126928391 | 12692839 | 4 | 20160408 | 201605 | 0 | |
126928391 | 12692839 | 5 | 20160330 | 20160423 | 0 | |
126928391 | 12692839 | 6 | 20160330 | 201605 | 0 | |
126928391 | 12692839 | 7 | 20160416 | 20160423 | 0 | |
126928391 | 12692839 | 8 | 20160330 | 201605 | 0 | |
126928391 | 12692839 | 9 | 20160412 | 20160419 | 0 |